TP53 and Leigh syndrome: Moreover, the lack of TP53 mutations in LS does not preclude its role as a VSCC precursor, as causes other than genetic could promote LS progression, such as epigenetic (hypermethylation or hydroxymethylation) [40,41] or immune factors [42].